Revenue (Tables)

9 Months Ended

Oct. 03, 2021

Revenue From Contract With Customer [Abstract]

Schedule of Balance of Contract Assets Recorded in Consolidated Balance Sheets

The balance of Contract assets recorded in the Company’s consolidated balance sheets were as follows:

	October 3, 2021		January 3, 2021
Other current assets	$	47.8	$	40.4
Other assets		0.8		2.4
Total contract assets	$	48.7	$	42.8

Summary of Net Revenue by Line of Business

The following table summarizes Net revenue by line of business for the fiscal quarter and nine months ended October 3, 2021 and September 27, 2020:

	Fiscal Quarter Ended				Fiscal Nine Months Ended
	October 3, 2021		September 27, 2020		October 3, 2021		September 27, 2020
Clinical Laboratories	$	336.6	$	300.1	$	993.9	$	816.7
Transfusion Medicine		170.7		140.6		494.5		414.5
Other Product Revenue		—		3.3		5.6		3.7
Total Product Revenue		507.4		444.1		1,494.1		1,234.9
Collaborations and Other Revenue		15.1		7.0		27.8		14.7
Net Revenue	$	522.5	$	451.1	$	1,521.8	$	1,249.6